NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Longfellow95 to HapLiberian:You need to realize that the big name journals, their peer reviewers, so-called KOL's, the medical media, and of course the regulator, are all tied up with Big Pharma.

It's what maintains the status quo.

And makes everything doubly difficult for NWBO.

I fully suspect it was a 'big name' journal who faffed about asking for revision after revision for 6 months, which eventually forced NWBO to go with JTM. A wise decision.

Imo, JTM with its open access policy is more reliable, and ultimately open to greater scrutiny.

My opinion.

BEST COMPREHENSIVE EXPLANATION versus previous waffling criticisms underscoring the previous delays!: COMMENDABLE & THOROUGHLY THOUGHT OUT reply for his Legal brothers to oversee!

Sojourner55 Saturday, 08/03/19 12:57:02 PM
Re: longfellow95 post# 238385
Post # 238402of 238404
Agree

"Imo, JTM with its open access policy is more reliable, and ultimately open to greater scrutiny."

The article has been accessed 35K times and 33 citations. [WOW: Splendid Thanks Sojourner]

https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6/metrics

DIFFERENT STROKES FOR DIFFERENT FOLKS